Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation
Payal Dhar1, Fahmin Basher2, Zhe Ji3,4
1Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Abstract:
Natural Killer (NK) cell dysfunction is associated with poorer clinical outcome in cancer patients. What regulates NK cell dysfunction in tumor microenvironment is not well understood. Here, we demonstrate that the human tumor-derived NKG2D ligand soluble MIC (sMIC) reprograms NK cell to secrete pro-tumorigenic cytokines with diminished cytotoxicity and polyfunctional potential. Antibody clearing sMIC restores NK cell to a normal cytotoxic effector functional state. We discovered that sMIC selectively activates the CBM-signalosome inflammatory pathways in NK cells. Conversely, tumor cell membrane-bound MIC (mMIC) stimulates NK cell cytotoxicity through activating PLC2γ2/SLP-76/Vav1 pathway. Ultimately, antibody targeting sMIC effectuated the in vivo anti-tumor effect of adoptively transferred NK cells. Our findings uncover an unrecognized mechanism that could instruct NK cell to a dysfunctional state in response to cues in the tumor microenvironment. Our findings provide a rationale for co-targeting sMIC to enhance the efficacy of the ongoing NK cell-based cancer immunotherapy.
Insights
Soluble MIC (sMIC) reprograms Natural Killer (NK) cells into a dysfunctional state within the tumor microenvironment. Clearing sMIC restores NK cell anti-tumor activity, offering a new target for cancer immunotherapy.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Signaling
Background:
- Natural Killer (NK) cell dysfunction correlates with poor clinical outcomes in cancer patients.
- The mechanisms regulating NK cell dysfunction within the tumor microenvironment remain unclear.
Purpose of the Study:
- To investigate the role of soluble MIC (sMIC) in reprogramming NK cell function in the tumor microenvironment.
- To elucidate the signaling pathways affected by sMIC and membrane-bound MIC (mMIC).
- To evaluate the therapeutic potential of targeting sMIC in NK cell-based cancer immunotherapy.
Main Methods:
- Demonstration of sMIC-induced NK cell reprogramming in vitro.
- Analysis of NK cell signaling pathways (CBM-signalosome, PLC2γ2/SLP-76/Vav1).
- In vivo studies using antibody-mediated sMIC clearance and adoptively transferred NK cells.
Main Results:
- Soluble MIC (sMIC) induces NK cell dysfunction, characterized by pro-tumorigenic cytokine secretion and reduced cytotoxicity.
- sMIC selectively activates CBM-signalosome inflammatory pathways in NK cells.
- Antibody-mediated clearance of sMIC restores NK cell cytotoxic effector function.
- Membrane-bound MIC (mMIC) activates a distinct pathway (PLC2γ2/SLP-76/Vav1) promoting NK cell cytotoxicity.
- Targeting sMIC enhanced the in vivo anti-tumor efficacy of adoptively transferred NK cells.
Conclusions:
- sMIC is a key factor in inducing NK cell dysfunction within the tumor microenvironment.
- Targeting sMIC represents a promising strategy to enhance NK cell-based cancer immunotherapy.
- Understanding sMIC-mediated signaling provides a rationale for novel therapeutic approaches in cancer treatment.
More Related Videos
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Tumor Microenvironment


